AN ANCIENT herbal remedy could reduce pain and inflammation and limit damage caused by arthritis, a new study showed. Its ...

Individuals with gout are more likely than those without the disease to receive chronic opioid therapy, independent of other ...

Like many physicians at this fraught time in medicine, I am watching television news now more than ever. Health care is ...

Uric acid, long seen as a simple waste product, can act as a biological alarm, triggering immune responses and inflammation ...

Expands Sobi’s pipeline with a highly differentiated new Phase 3 asset in GoutAcquisition expected to be highly accretive to Sobi’s mid- to long-term growth and margin trajectory Sobi® (STO:SOBI) has ...

Celery seed benefits include lower blood pressure, improved sexual function in women, and reduced cholesterol levels, but more human studies are needed.

The burden of cardiovascular-kidney-metabolic (CKM) comorbidities among adults with gout is high, noted Chio Yokose, MD, MSc, ...

Researchers identified 8 immune cell phenotypes that demonstrated causal associations with gout risk: 5 protective and 3 linked to increased risk. Interactions between immune cell phenotypes and gut ...

More than 1 in 4 of the top TikTok videos about gout were presented by patients with gout or close family members.

Several agents are available and generally effective for the treatment of gout; however, many are poorly tolerated, or contraindicated in patients with renal, cardiovascular or gastrointestinal ...

Here, we discuss three biotech stocks that put up a robust show in 2025 and are likely to maintain the same in 2026 on the back of a solid portfolio and a promising pipeline. These are EyePoint, Inc.